1. A preliminary assessment of longitudinal amyloid status in the ongoing open‐label extension phase in subjects with early Alzheimer's disease: Human/Human trials: Anti‐amyloid. (7th December 2020) Authors: Swanson, Chad J.; Zhang, Yong; Dhadda, Shobha; Wang, Jinping; Kaplow, June; Bradley, Heather; Rabe, Martin; Lai, Robert Y.K.; Gordon, Robert; Kramer, Lynn D. Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Amyloid burden assessed by three amyloid PET tracers in the elenbecestat MissionAD Phase 3 program: Neuroimaging / evaluating treatments. (7th December 2020) Authors: Roberts, Claire; Kaplow, June; Giroux, Monique; Krause, Stephen; Kanekiyo, Michio Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 4 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease. (31st December 2021) Authors: Lynch, Shau Yu; Irizarry, Michael C; Dhadda, Shobha; Li, David JianJun; Kanekiyo, Michio; Bogoslovsky, Tanya; Gee, Michelle; Reyderman, Larisa; Kaplow, June; Rabe, Martin; Hodgkinson, Mark; Kramer, Lynn D; Hampel, Harald; Swanson, Chad J Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Concordance of Lumipulse cerebrospinal fluid t‐tau/Aβ42 ratio with amyloid PET status. Issue 1 (8th January 2020) Authors: Kaplow, June; Vandijck, Manu; Gray, Julia; Kanekiyo, Michio; Huyck, Els; Traynham, C. J.; Esquivel, Rianne; Fagan, Anne M.; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 16:Issue 1(2020) Page Start: 144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DT‐01‐01: BAN2401 IN EARLY ALZHEIMER'S DISEASE: NEURODEGENERATION BIOMARKER ANALYSIS FROM A RANDOMIZED PHASE 2 STUDY. (1st July 2019) Authors: Molinuevo, Jose Luis; Koyama, Akihiko; Dhadda, Shobha; Irizarry, Michael C.; Swanson, Chad J.; Zhang, Yong; Kaplow, June; Bradley, Heather; Rabe, Martin; Totsuka, Keiichiro; Lai, Robert YK.; Gordon, Robert; Kramer, Lynn D. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 28 Page Start: P1484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DT‐01‐07: TREATMENT OF EARLY AD SUBJECTS WITH BAN2401, AN ANTI‐Aβ PROTOFIBRIL MONOCLONAL ANTIBODY, SIGNIFICANTLY CLEARS AMYLOID PLAQUE AND REDUCES CLINICAL DECLINE. (1st July 2006) Authors: Swanson, Chad J.; Zhang, Yong; Dhadda, Shobha; Wang, Jinping; Kaplow, June; Lai, Robert YK.; Lannfelt, Lars; Kramer, Lynn Darden; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7(2018)Part 31 Page Start: P1668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. IC‐P‐040: EVALUATION OF TAU DEPOSITION IN AMYLOID POSITIVE MCI OR MILD‐AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET. (1st July 2019) Authors: Stephens, Andrew Wills; Bullich, Santiago; Mueller, Andre; Berndt, Mathias; de Santi, Susan; Scott, David; Adamczuk, Kate; Suhy, Joyce; Kaplow, June; Krause, Stephen; Chang, Julia; Albala, Bruce; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 1 Page Start: P45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. O4‐11‐02: The path to regulatory qualification of cerebrospinal fluid biomarkers as enrichment tools in clinical trials of patients with early Alzheimer's disease: For the coalition against major diseases. (1st July 2015) Authors: Vanderstichele, Hugo Marcel; Stephenson, Diane; Shaw, Leslie M.; Carrillo, Maria; Umek, Robert; Rajapakse, Hemaka; Luthman, Johan; Soares, Holly; Gordon, Mark Forrest; Devanarayan, Viswanath; Genius, Just; Berman, Robert; Hendrix, James; Romero, Klaus; Kaplow, June; Willis, Brian; Hitchcock, Jani... Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7S:Part 6 Page Start: P296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. O4‐12‐05: EVALUATION OF TAU DEPOSITION IN AMYLOID‐POSITIVE MCI OR MILD AD DEMENTIA SUBJECTS FROM THE ELENBECESTAT MISSION AD PROGRAM USING [18 F]PI‐2620 PET. (1st July 2019) Authors: Stephens, Andrew Wills; Bullich, Santiago; Mueller, Andre; Berndt, Mathias; de Santi, Susan; Scott, David; Adamczuk, Kate; Suhy, Joyce; Kaplow, June; Krause, Stephen; Chang, Julia; Albala, Bruce; Luthman, Johan Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 24 Page Start: P1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P1‐040: ELENBECESTAT, A NOVEL BACE INHIBITOR, DEMONSTRATES SIMILAR PHARMACOKINETICS AND TOLERABILITY IN JAPANESE SUBJECTS WITH MULTIPLE DOSINGS. (1st July 2006) Authors: Hayata, Nozomi; Yasuda, Sanae; Kanekiyo, Michiwo; Ito, Satoshi; Yoshida, Masayo; Kawaguchi, Hiroyuki; Lai, Robert YK.; Kaplow, June; Albala, Bruce; Luthman, Johan; Tsuno, Masanori Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7S(2018)Part 5 Page Start: P282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗